Bioinformatic analysis of differentially expressed genes as prognostic markers in pheochromocytoma and paraganglioma tumors-Reference-Cited by-同舟云学术

Bioinformatic analysis of differentially expressed genes as prognostic markers in pheochromocytoma and paraganglioma tumors

Published:2021-04-01 Issue:2 Volume:96 Page:55-69
ISSN:1341-7568
Container-title:Genes & Genetic Systems
language:en
Short-container-title:Genes Genet. Syst.

Author:

Shi Zhen¹,Kong Xiaodi²,Li Cheng¹,Liu Hui¹,Aliagan Abdulhafiz Imam³,Liu Li³,Shi Yue⁴,Shi Xiao⁵,Ma Binbin¹,Jin Ruiqi⁵,Wang Shizhuo⁶,Pan Ding¹,Tang Juyu¹

Affiliation:

1. Department of Hand and Microsurgery, Xiangya Hospital, Central South University

2. Department of Urology, Xiangya Hospital, Central South University

3. Department of Cellular and Integrative Physiology, University of Texas Health Science Center at San Antonio

4. School of Mechanical Engineering, Northwestern Polytechnical University

5. The Third Xiangya Hospital, Central South University

6. College of Life Science and Technology, Beijing University of Chemical Technology

Publisher

Genetics Society of Japan

Subject

Genetics,Molecular Biology,General Medicine

Link

https://www.jstage.jst.go.jp/article/ggs/96/2/96_20-00057/_pdf

Reference47 articles.

1. Aida, K., Ikegishi, Y., Chen, J., Tawata, M., Ito, S., Maeda, S., and Onaya, T. (2000) Disruption of aldose reductase gene (Akr1b1) causes defect in urinary concentrating ability and divalent cation homeostasis. Biochem. Biophys. Res. Commun. 277, 281-286.

2. Baba, S. P., Wetzelberger, K., Hoetker, J. D., and Bhatnagar, A. (2009) Posttranslational glutathiolation of aldose reductase (AKR1B1): a possible mechanism of protein recovery from S-nitrosylation. Chem. Biol. Interact. 178, 250-258.

3. Barski, O. A., Tipparaju, S. M., and Bhatnagar, A. (2008) The aldo-keto reductase superfamily and its role in drug metabolism and detoxification. Drug Metab. Rev. 40, 553-624.

4. Binnewies, M., Roberts, E. W., Kersten, K., Chan, V., Fearon, D. F., Merad, M., Coussens, L. M., Gabrilovich, D. I., Ostrand-Rosenberg, S., Hedrick, C. C., et al. (2018) Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat. Med. 24, 541-550.

5. Burnichon, N., Vescovo, L., Amar, L., Libé, R., de Reynies, A., Venisse, A., Jouanno, E., Laurendeau, I., Parfait, B., Bertherat, J., et al. (2011) Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma. Hum. Mol. Genet. 20, 3974-3985.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aldo-keto reductase 1B: Much learned, much more to do;hLife;2023-12

2. AKR1B1 Represses Glioma Cell Proliferation through p38 MAPK-Mediated Bcl-2/BAX/Caspase-3 Apoptotic Signaling Pathways;Current Issues in Molecular Biology;2023-04-13

3. Moving toward a new horizon for the aldose reductase inhibitor epalrestat to treat drug-resistant cancer;European Journal of Pharmacology;2022-09

4. Altered protein profile of plasma extracellular vesicles in oral squamous cell carcinoma development;Journal of Proteomics;2022-01

5. miR‑425 regulates lipophagy via SIRT1 to promote sorafenib resistance in liver cancer;Oncology Letters;2021-08-02